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Abstract 
Background: Interventions targeting cognition in people with schizophrenia have shown 
moderate effects on improving functioning. Recent Cognitive Remediation (CR) approaches 
have begun to target metacognition to improve functioning outcomes. This study aims to 
develop a novel measure of metacognition and assess if metacognitive based CR (mCR) can 
improve metacognition. 
Methods: We use data from a single-blinded randomised controlled trial comparing mCR plus 
Treatment as Usual (TAU) to TAU alone in people with schizophrenia. Participants were 
assessed with measures of cognition, functioning and a new measure of metacognition at 
three time points: week-0 (baseline), week-12 and week-24. 
Results: The evaluation of the novel metacognition assessment suggests that it is a reliable 
and valid measure. The measure positively correlates with cognitive measures, in particular 
with executive function and IQ, but also with a measure of functioning. We found that a 
course of mCR was able to increase metacognition compared to TAU by week-24. 
Conclusions: Metacognition may be an important mechanism to explain how CR affects 
functioning outcomes in people with psychosis. The systematic assessment of metacognition 
as part of CR studies may help to evaluate more clearly its role and relevance to functioning.  
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Introduction 
 
Cognitive difficulties are a landmark feature of schizophrenia and recognised to be 
contributors to functioning difficulties (Wykes 1994, Keefe and Harvey 2012, Green and 
Harvey 2014). Cognitive remediation (CR) was developed in the attempt to reduce the impact 
of cognitive difficulties on functional outcome. CR is a psychological therapy which uses 
learning principles and behavioural techniques (e.g. massed practice and errorless learning) 
to improve cognition and ultimately to reduce functional difficulties. There are two main CR 
approaches, one based on drill and practice and one using drill and practice and strategy (Cella 
M. 2012). While drill and practice programmes rely solely on task practice to reduce cognitive 
difficulties, drill and practice plus strategy programmes actively teach strategy use to 
overcome cognitive difficulties and achieve functioning milestones. Evidence suggests that 
both these approaches are effective to improve cognition but drill and practice plus strategy 
is more effective in bringing about functioning improvements (Wykes, Huddy et al. 2011).   
A key unanswered question for CR programmes is how to maximise functioning 
improvements. While strategies have been shown to contribute to functioning 
improvements, increasing this therapy ingredient on its own may not be enough to deliver 
large changes. For example, if a CR program teaches strategies that people forget to use or 
are not able to use efficiently then introducing strategies alone may be unlikely to influence 
functioning. A well learned strategy in a particular context may also suffer from difficulties in 
being generalised and adapted to new situations. This may restrict the overall utility and 
applicability of strategies in CR. 
This is the context that prompted clinical researchers in this field to look for a process that 
can maximise the applicability and usefulness of strategies so that they can have a lasting and 
more significant effect on functioning difficulties. Research in people with psychosis has 
shown that metacognitive impairments are associated with difficulties in everyday life 
functioning including employment and social relationships (Koren, Seidman et al. 2006, 
Stratta, Daneluzzo et al. 2009, Lysaker, McCormick et al. 2011). Metacognition has also been 
suggested as a process that can aid strategy use and may extend their usefulness.  
Although several therapeutic approaches have attempted to target metacognition, they have 
used different definitions. While all definitions largely revolve around Flavell’s original 
conceptualisation of metacognition as the cognitive processes that relate to “thinking about 
thinking” (Flavell 1979), there are many subtle and sometime key differences in the way this 
term is used. Some proponents consider metacognition as the ability to make sense of one’s 
own and other people’s experiences (Lysaker and Dimaggio 2014). Others consider it a 
process responsible for illness insight and symptom awareness (Corcoran and Frith 2003, 
David, Bedford et al. 2012), and still others focus on narrower aspects of metacognition such 
as introspective accuracy, or the ability to accurately judge one’s own skills and abilities   
(Pinkham, Klein et al. 2018). In the context of Cognitive Behavioural Therapy for people with 
psychosis this concept has been associated with the ability to recognise and regulate thinking 
biases (Moritz and Woodward 2007, Morrison, Pyle et al. 2014). 
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We have proposed that metacognition is particularly suited to Cognitive Remediation (CR) as 
it regulates learning and behaviour and links the task specific learning to effective behaviour 
in key functioning domains such as employment, education and social life (Wykes and Reeder 
2005, Cella, Reeder et al. 2015, Cella, Reeder et al. 2015). We have proposed that two 
metacognitive functions are vital for translating cognitive to functional improvement. The first 
is metacognitive knowledge, which refers to knowledge of cognitive processes, such as 
someone’s beliefs about their own cognitive strengths and weaknesses. The second is 
metacognitive regulation, which is responsible for planning, monitoring and improving 
cognitive processes and behaviours through evaluation. Metacognitive regulation and 
knowledge can both support effective strategy use. For example, by planning what strategies 
best apply to a journey, evaluating different transport options, taking enough money and 
anticipating possible problems.  
Over the last ten years we have developed a CR programme targeting metacognitive 
knowledge and regulation alongside cognitive difficulties. The resulting therapy, called 
Computerised Interactive Remediation of Cognition–Interactive Training for Schizophrenia, or 
CIRCuiTS, is acceptable and feasible (Reeder, Pile et al. 2015). Recent research showed 
promising results for this therapy to improve cognitive difficulties and functioning (Reeder, 
Huddy et al. 2017). However, before we can investigate whether metacognitive CR effectively 
targets metacognitive processes we need a measure that can capture metacognitive 
regulation and knowledge. To this end the current study aims to: i) develop a metacognition 
measure based on task performance and strategy use and ii) evaluate whether 
metacognition-based CR can improve metacognition. 
 
Methods 
 
Design 
This study used data from a single blind randomised controlled trial comparing a novel 
metacognitive CR approach, called CIRCuiTS, plus treatment as usual (TAU) to TAU alone. A 
detailed description of this study methods can be found in Reeder et al., (Reeder, Huddy et 
al. 2017). Outcomes were measured at three time points: baseline (week-0), post-treatment 
(week-12) and follow-up (week-24).  
 
Participants  
Participants for this study were recruited via Community Mental Health Teams and 
Rehabilitation services from the South London and Maudsley Mental Health National Health 
Service (NHS) Foundation Trust.  Participant inclusion criteria were: (i) DSM-IV diagnosis of 
schizophrenia or schizo-affective disorder assessed with structured interview by a trained 
clinician, (ii) at least 1 year's contact with mental health services, (iii) 17–65 years, and (iv) 
performance more than one standard deviation below the normative mean in working 
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memory, as assessed by the digit span (Wechsler 2008) and/or cognitive flexibility, as 
assessed by the Wisconsin Card Sorting Test (WCST) (Heaton and Psychological Assessment 
Resources Inc. 1993) and/or executive function, as assessed by the Hayling Sentence 
Completion Test (Burgess and Shallice 1997). We chose to focus our inclusion criteria on these 
cognitive domains as they are strongly associated with functioning difficulties (Wykes, Reeder 
et al. 2012, Cella and Wykes 2017). Exclusion criteria were: (i) plans to change medication 
during the study, (ii) substance dependence or (iii) evidence of an organic cause to cognitive 
difficulties. 
 
Interventions 
Treatment-as-usual: This is routine psychiatric care offered by the service including 
individualised multi-disciplinary contacts for medication review and symptom and well-being 
monitoring. The professionals involved in these contacts were mostly psychiatrists and 
mental health nurses. Less frequently, psychologists, occupational therapists and residential 
support services were also offering relevant support. 
 
Metacognitive CR: CR was delivered by a therapist using CIRCuiTS, a web-based computerised 
software. Sessions with therapist were supplemented with independent sessions. In addition 
to providing massed practice of basic cognitive functions (e.g. memory, attention, executive 
function), the programme targets metacognition and encourages strategy use. The therapist’s 
role is centred around supporting motivation, strategy development and generalisation and 
teaching, as well as using metacognitive regulations skills to promote an understanding of 
cognitive and non-cognitive strengths and difficulties (i.e. metacognitive knowledge). The 
therapist also supports learning transfer to maximise participants real-world goals. Therapists 
provide additional scaffolding by simplifying task demands where needed and supporting 
clients’ motivation to ensure consistent successful performance. The software targets 
memory, executive functioning and attention. Tasks increase in difficulty gradually in line with 
participants performance to maintain high levels of success allowing for errorless learning. 
Participants also develop a set of personalised strategies to improve their cognitive 
performance and achieve their goals. 
At the beginning of the therapy, real-world goals are set collaboratively, and progress is 
reviewed regularly. Therapy sessions are offered at least three times a week (for maximum 
12 weeks), up to 40 sessions each lasting approximately one hour. Where possible, according 
to participants’ ability and choice, therapists encourage carrying out additional independent 
sessions. 
CIRCuiTS tasks are either ‘abstract’ (neutral content, such as numbers, and designed to target 
specific cognitive functions) or ‘exercises’ (cognitively complex and ecologically valid) 
associated with work, social situations, cooking, shopping and travelling. Therapists 
encourage participants to apply the skills learnt in daily life and to practice in vivo to achieve 
their real-world goals. Thus, functional outcomes are directly targeted by the therapy. 
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Measures  
Cognition 
Verbal working memory was assessed using Digit Span (WAIS-IV-UK) (Wechsler 2008), and we 
used the total raw score output with high scores being indicative of good performance.  
Visual memory was assessed with the Rey Osterreith Complex Figure (ROCF) (Meyers, Bayless 
et al. 1996), and we used the immediate recall raw score with high scores being indicative of 
good performance. 
Verbal executive function was assessed with the Hayling Sentence Completion test (Burgess 
and Shallice 1997), and we used the total scaled score with high scores being indicative of 
good performance. 
Visual executive function was assessed with the Wisconsin Card Sorting Task (WCST) (Heaton 
and Psychological Assessment Resources Inc. 1993), testing abstraction and cognitive 
flexibility. We used the percentage of errors with high scores being indicative of poor 
performance. 
Current IQ was estimated using the Vocabulary and Block Design tests from the Wechsler 
Adult Intelligence Scale – Third Edition – UK (Christensen, Girard et al. 2007).  
Functioning  
Functioning was assessed using the  Time Use Survey (UK 2000 Time Use Survey - Short 2006). 
This is a semi-structured interview recording how participants use their time which has been 
adapted for use with people with psychosis (Cella, Edwards et al. 2016). Key outcomes of this 
measure are expressed in total hours per week over the past month spent in structured 
activities including employment, education, voluntary employment, structured leisure 
activities, housework and chores, childcare, sports and hobbies.  
 
Symptoms  
Symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS) (Kay, 
Fiszbein et al. 1987). This is a 30-item structured clinical interview assessing symptom 
severity. For this study we considered three symptoms dimensions: positive, negative and 
general symptoms. 
 
 
Metacognition  
This measure assessed how participants approach two cognitive tasks: the Rey-Osterreith 
Complex Figure (ROCF) and the Hayling Sentence Completion test. Performance on both these 
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tasks benefit from the implementation of strategy. We assessed four metacognitive 
components: 
(1) Understanding, monitoring and evaluating: assess the participant’s ability to acknowledge 
having mental functions, distinguish between mental operations using cognitive words (i.e. 
memorising, realising and imaging) and evaluate their task performance. 
(2) Strategy implementation: evaluates whether the individual knew how they completed the 
task, if they acknowledge using a strategy which was either effective or ineffective, their 
capability to label and describe the strategy, as well as evaluating their chosen method. 
(3) Objective strategy: assesses whether a clear and objective strategy was used to complete 
the task.  
(4) Strategy congruence: evaluates whether the subjective strategy stated is congruent with 
the cognitive demands of the task and to what degree the strategy was implemented (e.g. 
only at the beginning and then dropped; during whole the task). This is evaluated by the 
interviewer and together objective strategy represents an index of metacognition 
independent from the participants’ ability to describe strategy use, which may be indirectly 
supported by CR. 
For each of these items participants answer, or performance is scored on a 0-3 scale. Raters 
were provided with a scoring manual with each score level anchoring description and 
examples. Lower scores indicate lack of or difficulties in the application and use of that 
metacognitive function while high scores are evidence of domain mastery. The total scale 
score is the sum of the four items scores and it ranges from 0 to 12. Each interview was scored 
independently by two raters and each score discrepancy that could not be resolved was 
discussed with a third senior author and a final score agreed. 
The measure was administered as a structured interview after the administration of the text 
was completed. All interviews were audio recorded and transcribed. To ensure the reliability 
of each metacognition transcript, every transcript was assessed for interviewer adherence to 
the script, using a rating scale ranging from 0 (poor adherence) to 3 (highly adherent). Poor 
adherence reflects the interviewer inadvertently suggesting strategies or using words that 
could prompt the participants to use reflective language (e.g. what were you thinking while 
doing the task). Any transcript rated as 0 or 1 was excluded from the analysis. Scoring on 
Understanding, monitoring and evaluating and Strategy implementation was performed on 
interview transcripts while scoring on the Objective strategy and Strategy congruence was 
performed by the rater on the bases of the observed behaviour or the relevance of the 
strategy use to the task. 
  
Analysis 
We investigated the psychometric properties of our novel metacognitive measure. As two 
(i.e. metacognitive understanding and subjective strategy use) out of the four interview items 
rely on raters’ scores, we calculated inter-rater reliability from two independent raters using 
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a Cohen’s Kappa. Interpretation of Kappa levels was based on Viera and Garrett (Viera and 
Garrett 2005). 
We evaluated the distribution properties of each measure considered by exploring 
distributional parameters (e.g. skewness) and using Shapiro-Wilks test to assess normality. 
We assessed correlation using Pearson correlation coefficients. 
Scale reliability was measured by Cronbach's alpha coefficient. Conventionally, alpha values 
above 0.70 are considered satisfactory (Bland and Altman 1997). We evaluated the new 
metacognitive measure’s construct validity using correlations with cognitive domains, 
functioning levels and symptom domains using Pearson correlation coefficients.  
To explore whether metacognitive CR can improve scores on our novel metacognitive 
measure we conducted a mixed effect ANCOVA. The model considered the baseline score 
(week-0) of the metacognition measure as a covariate. The model considered time at Post -
therapy (week-12) and Follow-up (week-24) assessments, treatment group (i.e. CR and TAU 
alone) and the interaction between time and group as fixed categorical variables. Partial eta 
squares are reported for effect size estimates. 
 
Results 
Of the 93 participants recruited in the study 76 completed the metacognitive interview. 
Reasons for non-completion were: not providing consent for the interview recording (11), 
recorder not available (3), poor audio quality or partial recording (3). Of these 76 interviews, 
9 were rated as unreliable due to excessive interviewer influence or interviewer not following 
the script. Percentage of missing data from the 67 participants who took part was: 6% at 
baseline assessment; 12% at 12-week assessment and 19% at 24-week assessment. 
Participants were mostly men (61%) and had an average age of 39.6 (SD 10.7). They all 
received antipsychotic medications with an average chlorpromazine level of 421.6 (SD323.9).  
 
Metacognitive measure 
Inter-rater agreement on interview scoring across the three assessment points for 
Understanding, Monitoring and Evaluating and Strategy Implementation were between 0.38 
and 0.51. This is indicative of a fair to moderate inter-rater agreement. All disagreements 
were discussed and resolved with the help of a third author. 
The scale reliability for baseline assessments was evaluated using Cronbach alpha and was 
0.78.  
The scale items intercorrelation ranged between 0.82 (p<0.001) for the correlation between 
Strategy Congruence and Objective Strategy Use to 0.29 (p<0.001) for the correlation 
between Understanding, Monitoring and Evaluating and Objective Strategy Use. 
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Correlations between the metacognitive measure total score and the cognitive and symptoms 
measures at week-0 are reported in Table 1. 
 
 
 
 
------------- Table 1 about here ------------ 
 
 
 
 
The measure has moderate levels of correlation with executive function measures and 
modest relations with functioning and negative symptoms. 
 
Is metacognitive CR improving metacognition? 
Of the 67 participants considered 34 were randomised to CR and 33 to TAU.  
Figure 1 shows the metacognitive mean scores for the CR and the TAU groups. ANCOVA 
analysis showed no group by time interaction at week-12 F(1,56)=1.9, p=0.17, η2=0.03 (mean 
difference=0.75; SE 0.17) but did show a significant group by time interaction at week-24 
F(1,51)=6.5, p=0.01, η2=0.15 (mean difference=1.38; SE 0.51) suggesting that metacognition 
scores improve significantly by week-24 in the CR group compared to TAU. 
 
 
-------------Figure 1 about here--------- 
 
 
 
Discussion 
 
Metacognition is a key element of an effective cognitive system allowing individuals to expand 
knowledge and effectively understand, control, and manipulate their own cognitive processes 
(Flavell 1979). Metacognitive skills also allow individuals to be more flexible and able to cope 
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with a rapidly changing environment. A wealth of research demonstrates that metacognition 
is important for learning and acquiring new skills and that individuals who have higher levels 
of metacognition tend to perform better in studies and work (Kentridge and Heywood 2000, 
Hong, Vadivelu et al. 2015). Similarly, research conducted in people with psychosis supports 
the notion that difficulties in metacognition are associated with higher levels of functioning 
difficulties. This is the rationale that prompted us to develop a cognitive remediation 
programme targeting metacognition to maximise its effects on functioning.  
The results of this study showed that the new measure is feasible, and most trial participants 
were able to complete it. One aspect to consider in future studies is interviewer training as 
we lost 10% of participants’ results because of a lack of adherence to the script. This lack of 
adherence occurred mostly at the beginning of the session and it was soon rectified in 
supervision sessions. So future studies using this measure should maintain close monitoring 
on how the measure is administered. The psychometric proprieties of the novel 
metacognitive measure were found to be acceptable. As with all interviewer-based 
assessments, rater agreement is crucial to the sensitivity of the measure and appropriate 
training for raters is necessary.  
The correlations between the metacognition items and the internal consistency values 
suggest that the domains considered appear to be part of the same construct. This is 
important as it provides reassurance that the items representing the theoretical constructs 
are related to each other. While it is plausible to link effective strategy use to good 
metacognitive skills, it is reassuring that our measure shows links between effective strategy 
deployment and good metacognitive regulation. We consider this an important aspect that 
differentiates our programme from compensatory CR programmes where strategy may be 
provided, but limited consideration is given to how these are regulated and implemented.  
The correlation results, presented in table 1, suggest that the new metacognitive measure is 
related more to executive function than other cognitive domains. This is not a new finding 
and is in line with previous research suggesting that metacognition and executive functions 
may be partly overlapping concepts (Follmer and Sperling 2016).  
It is not clear from the literature, however, if metacognitive gains, after therapy, are 
independent from executive function. Part of our concept of metacognition, metacognitive 
regulation, is similar to self-regulation and considers cognitive skills necessary to plan, 
monitor and evaluate behaviours, including strategy use.  The effect of metacognitive CR on 
executive function, as reported in Reeder et al., (Reeder, Huddy et al. 2017), suggests that a 
course of this therapy can improve performance on executive function and this effect may 
not be independent from the effect on metacognition. It may be that metacognition exerts 
an effect on functioning via executive functions but also directly via metacognitive 
knowledge. Planning a visit to a family member should be positively affected by planning 
skills, but realising that the plan may be poorly executed on a low mood day may equally be 
important and prevent failure.    
Our measure is based largely on how participants approach a task and deal with its cognitive 
demands, apply and regulate strategies and it is different to other conceptualisations (e.g. 
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Moritz and Lysaker 2018). As such our measure is more akin to performance-based 
assessments such as neuropsychological tests however, we consider this concept still within 
the family of metacognition on the bases this is an essential process regulating behaviour. 
Most of the research to date has measured metacognition using self-assessment measures 
(e.g. Barbato, Penn et al. 2014) and this may be problematic, particularly in people with 
psychosis. Research suggests, in fact that there is a discrepancy between self-assessed, 
interviewer based and performance-based measures (Medalia and Thysen 2010, Cella, Swan 
et al. 2014). It is therefore likely that a performance-based measure of metacognition may 
better captures how metacognitive skills are deployed in everyday life and how they may 
influence functioning. The correlation between our metacognitive and functioning measure, 
as presented in table 1, suggests the amount of time people spend in structured activities in 
their everyday life is associated with their metacognitive competencies and strategy 
implementation skills. 
In this study we showed, for the first time, that our CR approach was effective in improving 
metacognitive scores compared to TAU. This is important as it shows that the measure is 
sensitive to change and that the therapy program targets the intended competencies. What 
remains to be established is whether and how metacognitive improvement transfers to 
functional gains. Result of this study, reported in Reeder at al.,  (Reeder, Huddy et al. 2017), 
found that individuals in the CR group improved their functioning at post-therapy, but these 
gains were not maintained at follow-up. This effect was likely due to the lack of opportunities 
and support participants were experiencing after therapy and this might have resulted in 
limited opportunities to expand functioning levels.  Despite the lack of functioning 
improvement at follow-up in this study we showed that metacognitive levels are different 
between the groups and significantly higher in the metacognitive CR group. This suggests that 
improving metacognition alone may not be sufficient for people who experience high levels 
of social and functioning difficulties and that providing opportunities to deploy new strategies 
may be a necessary precondition for programmes to have a lasting effect on functioning.  
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Figure 1 
 
 
 
 
 
Figure 1 Shows mean metacognition scores at week-0, -12 and -24 for the CR and TAU groups.  
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Table1 
 
 
Measure Metacognition  
(total score) 
Rey recall  
(memory) 
0.28* 
Digit Symbol  
(processing speed) 
0.23 
WCST errors  
(executive function) 
-0.43** 
Digit Span  
(working memory) 
0.35** 
Hayling errors  
(executive function)  
-0.55** 
WTAR  
(premorbid IQ) 
0.42** 
IQ 
 
0.51** 
Time Use SA  
(functioning) 
0.35** 
PANSS positive 
 
-0.2 
PANSS negative 
 
-0.33** 
PANSS general 
 
-0.01 
 
 
 
Table 1 Shows the correlation between the total metacognitive measure score, cognitive 
performance and symptoms. *p<.05; ** p<0.001. 
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